Endothelin antagonism and sodium glucose Co-transporter 2 inhibition. A potential combination therapeutic strategy for COVID-19

The novel coronavirus 2019 (COVID-19) infection caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a global pandemic that requires a multi-faceted approach to tackle this unprecedent health crisis. Therapeutics to treat COVID-19 are an integral part of any such management stra...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Pulm Pharmacol Ther
Autors principals: Fisk, Marie, Althage, Magnus, Moosmang, Sven, Greasley, Peter J., Cope, Andrew P., Jayne, David RW., Galloway, James, Hall, Frances, Wilkinson, Ian B., Ambery, Philip, Cheriyan, Joseph
Format: Artigo
Idioma:Inglês
Publicat: The Authors. Published by Elsevier Ltd. 2021
Matèries:
Review
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC8084922/
https://ncbi.nlm.nih.gov/pubmed/33933611
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.pupt.2021.102035
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars